Profil bibliographique

Adnan Nagrial

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

382Publications signalées

26855Citations signalées

6Affiliations récentes

Institutions déclarées

Camden and Campbelltown Hospitals The University of Sydney Blacktown & Mount Druitt Hospital Westmead Hospital Migration Institute of Australia Westmead Institute

Domaines associés

Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies

Publications récentes

Accès ouvert 2026 otherOpenAlex

Data from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial

Adnan Nagrial, Matteo S. Carlino, Ashray Gunjur, Michael P. Brown et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial

Adnan Nagrial, Matteo S. Carlino, Ashray Gunjur, Michael P. Brown et autres

0 citations

Accès ouvert 2026 articleOpenAlex

Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance

Jia Liu, Max Farrow, Sandra S. Hsing, Rasha Cosman et autres

0 citationsClinical Cancer Research

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figures S1-S22 from Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S2 from Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S3 from Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Data from Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citations

2026 articleOpenAlex

Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial

Adnan Nagrial, Matteo S. Carlino, Ashray Gunjur, Michael P. Brown et autres

1 citationClinical Cancer Research

2026 conference-abstractOpenAlex

Abstract CT304: Narmafotinib (AMP945) in combination with gemcitabine and nab-paclitaxel in first-line patients with advanced pancreatic cancer (ACCENT trial) a Phase 1b 2a study-Interim analysis

Terrie-Anne Cock, Sumitra Ananda, Choong-kun Lee, Nick Pavlakis et autres

0 citationsCancer Research

2026 articleOpenAlex

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts

Adel T. Aref, Mohashin Pathan, Rosemary Habib, Peter G. Hains et autres

0 citationsClinical Cancer Research

Accès ouvert 2026 articleOpenAlex

RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer

Udit Nindra, Jun Hee Hong, Martin Hong, Stephanie Lim et autres

0 citationsCancer Treatment and Research Communications

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.